Results of Kidney Transplantation From ABO-Incompatible Living Donors in a Single Institution

Takashi Kenmochi, K. Saigo, M. Maruyama, N. Akutsu, C. Iwashita, K. Otsuki, Taihei Ito, A. Suzuki, M. Miyazaki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

ABO-incompatible kidney transplantation has become a popular alternative to kidney transplantation in Japan because of the severe shortage of cadaveric donors. In our institution, 21 cases of ABO-incompatible kidney transplantation were performed from April 2004, to October 2007. Recipient age was 42.8 ± 14.5 years old; there were 9 men and 12 women. Duration of hemodialysis was 1,914 ± 2,343 days. Donor operation was performed using a complete laparoscopic procedure. Recipient's splenectomy was performed using a hand-assisted laparoscopic procedure and kidney transplantation was performed with a standard method using an extraperitoneal approach. Pretransplant immunosuppressive protocol includes an administration of mycophenolate mofetil, tacrolimus, predonisolone, splenectomy, double filtration plasmapheresis (DFPP), and plasma exchange (PE). All patients showed an immediate graft function and their serum creatinine levels promptly decreased to 1.48 ± 0.99 mg/dL on day 7 and 1.21 ± 0.72 mg/dL on day 30. Both immunoglobulin (Ig)M and IgG titers were maintained at much lower levels for 7 days after transplantation in all patients. Cytomegalovirus antigenemia was observed in 11 patients (52.4%). One patient (4.8%) developed a Pneumocystis Carinii pneumonia and the formation of lymphocele was observed in one patient (4.8%). Total patient survival at 3 years was 95.2%, and graft survival at 3 years was 90.5%, which were almost equal to those in the patients who underwent ABO-matched, compatible kidney transplantation.

Original languageEnglish
Pages (from-to)2289-2291
Number of pages3
JournalTransplantation Proceedings
Volume40
Issue number7
DOIs
Publication statusPublished - 01-09-2008

Fingerprint

Living Donors
Kidney Transplantation
Splenectomy
Tissue Donors
Lymphocele
Mycophenolic Acid
Plasma Exchange
Pneumocystis Pneumonia
Plasmapheresis
Tacrolimus
Graft Survival
Immunosuppressive Agents
Cytomegalovirus
Immunoglobulin M
Renal Dialysis
Creatinine
Japan
Hand
Immunoglobulin G
Transplantation

All Science Journal Classification (ASJC) codes

  • Surgery
  • Transplantation

Cite this

Kenmochi, Takashi ; Saigo, K. ; Maruyama, M. ; Akutsu, N. ; Iwashita, C. ; Otsuki, K. ; Ito, Taihei ; Suzuki, A. ; Miyazaki, M. / Results of Kidney Transplantation From ABO-Incompatible Living Donors in a Single Institution. In: Transplantation Proceedings. 2008 ; Vol. 40, No. 7. pp. 2289-2291.
@article{93b3a4c77e034823882e2c02d82f6076,
title = "Results of Kidney Transplantation From ABO-Incompatible Living Donors in a Single Institution",
abstract = "ABO-incompatible kidney transplantation has become a popular alternative to kidney transplantation in Japan because of the severe shortage of cadaveric donors. In our institution, 21 cases of ABO-incompatible kidney transplantation were performed from April 2004, to October 2007. Recipient age was 42.8 ± 14.5 years old; there were 9 men and 12 women. Duration of hemodialysis was 1,914 ± 2,343 days. Donor operation was performed using a complete laparoscopic procedure. Recipient's splenectomy was performed using a hand-assisted laparoscopic procedure and kidney transplantation was performed with a standard method using an extraperitoneal approach. Pretransplant immunosuppressive protocol includes an administration of mycophenolate mofetil, tacrolimus, predonisolone, splenectomy, double filtration plasmapheresis (DFPP), and plasma exchange (PE). All patients showed an immediate graft function and their serum creatinine levels promptly decreased to 1.48 ± 0.99 mg/dL on day 7 and 1.21 ± 0.72 mg/dL on day 30. Both immunoglobulin (Ig)M and IgG titers were maintained at much lower levels for 7 days after transplantation in all patients. Cytomegalovirus antigenemia was observed in 11 patients (52.4{\%}). One patient (4.8{\%}) developed a Pneumocystis Carinii pneumonia and the formation of lymphocele was observed in one patient (4.8{\%}). Total patient survival at 3 years was 95.2{\%}, and graft survival at 3 years was 90.5{\%}, which were almost equal to those in the patients who underwent ABO-matched, compatible kidney transplantation.",
author = "Takashi Kenmochi and K. Saigo and M. Maruyama and N. Akutsu and C. Iwashita and K. Otsuki and Taihei Ito and A. Suzuki and M. Miyazaki",
year = "2008",
month = "9",
day = "1",
doi = "10.1016/j.transproceed.2008.06.039",
language = "English",
volume = "40",
pages = "2289--2291",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "7",

}

Kenmochi, T, Saigo, K, Maruyama, M, Akutsu, N, Iwashita, C, Otsuki, K, Ito, T, Suzuki, A & Miyazaki, M 2008, 'Results of Kidney Transplantation From ABO-Incompatible Living Donors in a Single Institution', Transplantation Proceedings, vol. 40, no. 7, pp. 2289-2291. https://doi.org/10.1016/j.transproceed.2008.06.039

Results of Kidney Transplantation From ABO-Incompatible Living Donors in a Single Institution. / Kenmochi, Takashi; Saigo, K.; Maruyama, M.; Akutsu, N.; Iwashita, C.; Otsuki, K.; Ito, Taihei; Suzuki, A.; Miyazaki, M.

In: Transplantation Proceedings, Vol. 40, No. 7, 01.09.2008, p. 2289-2291.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Results of Kidney Transplantation From ABO-Incompatible Living Donors in a Single Institution

AU - Kenmochi, Takashi

AU - Saigo, K.

AU - Maruyama, M.

AU - Akutsu, N.

AU - Iwashita, C.

AU - Otsuki, K.

AU - Ito, Taihei

AU - Suzuki, A.

AU - Miyazaki, M.

PY - 2008/9/1

Y1 - 2008/9/1

N2 - ABO-incompatible kidney transplantation has become a popular alternative to kidney transplantation in Japan because of the severe shortage of cadaveric donors. In our institution, 21 cases of ABO-incompatible kidney transplantation were performed from April 2004, to October 2007. Recipient age was 42.8 ± 14.5 years old; there were 9 men and 12 women. Duration of hemodialysis was 1,914 ± 2,343 days. Donor operation was performed using a complete laparoscopic procedure. Recipient's splenectomy was performed using a hand-assisted laparoscopic procedure and kidney transplantation was performed with a standard method using an extraperitoneal approach. Pretransplant immunosuppressive protocol includes an administration of mycophenolate mofetil, tacrolimus, predonisolone, splenectomy, double filtration plasmapheresis (DFPP), and plasma exchange (PE). All patients showed an immediate graft function and their serum creatinine levels promptly decreased to 1.48 ± 0.99 mg/dL on day 7 and 1.21 ± 0.72 mg/dL on day 30. Both immunoglobulin (Ig)M and IgG titers were maintained at much lower levels for 7 days after transplantation in all patients. Cytomegalovirus antigenemia was observed in 11 patients (52.4%). One patient (4.8%) developed a Pneumocystis Carinii pneumonia and the formation of lymphocele was observed in one patient (4.8%). Total patient survival at 3 years was 95.2%, and graft survival at 3 years was 90.5%, which were almost equal to those in the patients who underwent ABO-matched, compatible kidney transplantation.

AB - ABO-incompatible kidney transplantation has become a popular alternative to kidney transplantation in Japan because of the severe shortage of cadaveric donors. In our institution, 21 cases of ABO-incompatible kidney transplantation were performed from April 2004, to October 2007. Recipient age was 42.8 ± 14.5 years old; there were 9 men and 12 women. Duration of hemodialysis was 1,914 ± 2,343 days. Donor operation was performed using a complete laparoscopic procedure. Recipient's splenectomy was performed using a hand-assisted laparoscopic procedure and kidney transplantation was performed with a standard method using an extraperitoneal approach. Pretransplant immunosuppressive protocol includes an administration of mycophenolate mofetil, tacrolimus, predonisolone, splenectomy, double filtration plasmapheresis (DFPP), and plasma exchange (PE). All patients showed an immediate graft function and their serum creatinine levels promptly decreased to 1.48 ± 0.99 mg/dL on day 7 and 1.21 ± 0.72 mg/dL on day 30. Both immunoglobulin (Ig)M and IgG titers were maintained at much lower levels for 7 days after transplantation in all patients. Cytomegalovirus antigenemia was observed in 11 patients (52.4%). One patient (4.8%) developed a Pneumocystis Carinii pneumonia and the formation of lymphocele was observed in one patient (4.8%). Total patient survival at 3 years was 95.2%, and graft survival at 3 years was 90.5%, which were almost equal to those in the patients who underwent ABO-matched, compatible kidney transplantation.

UR - http://www.scopus.com/inward/record.url?scp=51249119867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51249119867&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2008.06.039

DO - 10.1016/j.transproceed.2008.06.039

M3 - Article

VL - 40

SP - 2289

EP - 2291

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 7

ER -